Answers are grounded in this paper and cite their sources.
L-Glutamine is a treatment for children and adults with sickle cell disease. A comprehensive evaluation of the pharmacokinetics of L-glutamine in sickle cell disease has not been conducted. We aimed to assess the effects of long-term dosing, multiple dose levels, and food intake on L-glutamine exposure in patients with sickle cell disease compared to normal participants.
No takes yet. Share an insight, caveat, or question.
Sadaf et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: